Assessing Eating Disorder Prevalence and Associated Mortality Rates
Investigators study the association between increased treatment coverage and eating disorder-related mortality.
Psychiatry Information Center
Viloxazine NDA Submitted for Review as Potential New ADHD Treatment
The New Drug Application (NDA) for viloxazine hydrochloride (SPN-812; Supernus Pharmaceuticals), a serotonin norepinephrine modulating agent, has been submitted to the Food and Drug Administration (FDA) for the treatment of pediatric patients with attention deficit hyperactivity disorder (ADHD).
Video Games, TV Negatively Affect Child, Teen Academic Performance
Watching television and playing video games negatively affects academic performance in children and adolescents but overall screen time does not, according to research results published in JAMA Pediatrics. Television and video games both affected composite scores, while television negatively impacted language and mathematics skills. In a systematic review and meta-analysis, investigators aimed to determine whether…
Psychosocial Adversity in Children of Undocumented Parents
Pediatricians are likely to encounter children of undocumented parents during practice, making it essential for practitioners to be aware of the unique vulnerabilities faced by this population, as well as appropriate clinical procedure.
Adolescent Girls Using Oral Contraceptives Have Higher Self-Reported Depressive Symptoms
Symptoms of depression are associated with oral contraceptive use in 16-year-old girls compared with adolescents and young women up to 25 years of age.
Internalized Stigma Sets Up Barriers to Mental Health Care
The authors examined 3 hypotheses: internalized stigma would be a stronger predictor of barriers to seeking mental health care than perceived stigma, alienation would be a stronger predictor of barriers than other components, and depression severity would modify the relationship of depression stigma and barriers to care.
Risk for Suicide Increased After Hospital Discharge for Self-Harm
Authors say there is need for early follow-up care and attention to risk reduction strategies.
Pediatric Obesity Treatment Not Associated With Increased Risk for Anxiety, Depression
Researchers used patient databases to investigate the association between obesity treatment interventions with a dietary component and the change in symptoms of depression and anxiety in pediatric patients who were overweight or obese.
Depression Linked to Increased Clinical Burden, Hospitalization Risk in COPD
Depression is linked to increased clinical burden in patients with COPD.
Many Adult Health Problems Due to Adverse Childhood Experiences
Adverse childhood experiences significantly linked to poorer health outcomes, health risk behaviors.
Borderline Personality Disorder May Raise Cardiometabolic Risk
Borderline personality traits, depression associated with extent of midlife cardiometabolic risk.
Factors Correlated With Suicidal Ideation in Major Depressive Disorder
Higher rates of hopelessness, loneliness, anhedonia, social anxiety, and younger age were highly correlated with suicidal ideation in patients with major depressive disorder, based on a review of qualitative data.
Lofexidine May Effectively Mitigate Symptoms of Opioid Withdrawal Syndrome
Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.
Discontinuing Esketamine Nasal Spray Not Linked to Withdrawal Syndrome in Treatment-Resistant Depression
Discontinuing short- or long-term use of esketamine nasal spray for treatment-resistant depression may not be associated with withdrawal symptoms.
Dasotraline Improves Body Weight, Compulsive Behaviors in Binge Eating Disorder
Dasotraline may reduce compulsions and obsessive thoughts in adults with binge eating disorder.
Relapse More Likely With Antipsychotic Switch in Schizophrenia, Bipolar Disorder, or MDD
Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.
Evidence for Use of Cannabinoids to Treat Mental Disorders Lacking
There is little evidence to suggest that cannabinoids improve mental disorders.
Growing Number of PAs Seeing, Treating Mental Health Disorders
Researchers sought to document and describe the contributions of certified PAs across practice areas in addressing mental health conditions.
Psychotherapy for Depression May Be Cost-Effective Over Time
For patients with major depressive disorder, neither second-generation antidepressants nor cognitive behavioral therapy offers consistently superior cost-effectiveness.
New Medication Combination Promising for Adolescent Borderline Personality Disorder
Off-label use of oxcarbazepine and amantadine HCl appeared effective in maintaining improved symptomology in adolescent female patients with borderline personality disorder.
Want to read more?
Please login or register first to view this content.
Next post in Psychiatry Information Center
